Hemalatha G. Rangarajan
Nationwide Children's Hospital(US)The Ohio State University(US)
Publications by Year
Research Areas
Hematopoietic Stem Cell Transplantation, Hemoglobinopathies and Related Disorders, Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, Childhood Cancer Survivors' Quality of Life
Most-Cited Works
- → Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future(2021)75 cited
- → Safety Profile of Good Manufacturing Practice Manufactured Interferon γ-Primed Mesenchymal Stem/Stromal Cells for Clinical Trials(2017)70 cited
- → Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases(2017)58 cited
- → CD33 CAR T-Cells (CD33CART) for Children and Young Adults with Relapsed/Refractory AML: Dose-Escalation Results from a Phase I/II Multicenter Trial(2023)53 cited
- → Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT(2020)49 cited
- → A Novel Pathogenic Variant in CARMIL2 (RLTPR) Causing CARMIL2 Deficiency and EBV-Associated Smooth Muscle Tumors(2020)39 cited